VI
OCDX

Versor Investments’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

Versor Investments’s Portfolio OCDX Stock Details OCDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-5,163,657
Closed -$96.4M – 965
2022
Q1 		$96.4M Buy
5,163,657
+749,705
+17% +$13.5M 3.6% 9
2021
Q4 		$94.4M Buy
4,413,952
+4,395,806
+24,225% +$86.6M 2.85% 9
2021
Q3 		$335K Buy
+18,146
New +$365K 0.01% 352

Other funds holding OCDX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Versor Investments's OCDX Position: Q2 2022 in Review

Versor Investments sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q2 2022, closing a stake of 5,163,657 shares — an estimated $96.4M sold.

Versor Investments first reported a position in OCDX in Q3 2021 and held it in 3 quarters. The position peaked at $96.4M in Q1 2022. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.

  • Versor Investments reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q2 2022 after selling out during the quarter.
  • Versor Investments sold 5,163,657 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q2 2022, an estimated $96.4M.
  • Versor Investments first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q3 2021 and held it in 3 quarters.
  • Versor Investments's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $96.4M in Q1 2022.
  • 1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q2 2022.

Based on Versor Investments's 13F filing for Q2 2022, filed 27 Jul 2022.